These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31758015)

  • 1. Histone deacetylase inhibitors with high in vitro activities against Plasmodium falciparum isolates collected from Gabonese children and adults.
    Koehne E; Kreidenweiss A; Zoleko Manego R; McCall M; Mombo-Ngoma G; Mackwitz MKW; Hansen FK; Held J
    Sci Rep; 2019 Nov; 9(1):17336. PubMed ID: 31758015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
    Diedrich D; Stenzel K; Hesping E; Antonova-Koch Y; Gebru T; Duffy S; Fisher G; Schöler A; Meister S; Kurz T; Avery VM; Winzeler EA; Held J; Andrews KT; Hansen FK
    Eur J Med Chem; 2018 Oct; 158():801-813. PubMed ID: 30245402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of peptoid-based heteroaryl-decorated histone deacetylase (HDAC) inhibitors with dual-stage antiplasmodial activity.
    Stopper D; de Carvalho LP; de Souza ML; Kponomaizoun CE; Winzeler EA; Held J; Hansen FK
    Eur J Med Chem; 2024 Nov; 277():116782. PubMed ID: 39208744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites.
    Engel JA; Jones AJ; Avery VM; Sumanadasa SD; Ng SS; Fairlie DP; Skinner-Adams T; Andrews KT
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):117-26. PubMed ID: 26199860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages.
    Hansen FK; Sumanadasa SD; Stenzel K; Duffy S; Meister S; Marek L; Schmetter R; Kuna K; Hamacher A; Mordmüller B; Kassack MU; Winzeler EA; Avery VM; Andrews KT; Kurz T
    Eur J Med Chem; 2014 Jul; 82():204-13. PubMed ID: 24904967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Fairlie DP; Tjitra E; Anstey NM; Andrews KT; Price RN
    Antimicrob Agents Chemother; 2011 Mar; 55(3):961-6. PubMed ID: 21135175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor.
    Soumyanarayanan U; Ramanujulu PM; Mustafa N; Haider S; Fang Nee AH; Tong JX; Tan KSW; Chng WJ; Dymock BW
    Eur J Med Chem; 2019 Dec; 184():111755. PubMed ID: 31627059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing Anticancer Drugs To Tackle Malaria.
    Le Govic Y; Houzé S; Papon N
    ChemMedChem; 2021 Jul; 16(14):2192-2194. PubMed ID: 33931947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.
    Kreidenweiss A; Kremsner PG; Mordmüller B
    Malar J; 2008 Sep; 7():187. PubMed ID: 18816382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial activity of the anticancer histone deacetylase inhibitor SB939.
    Sumanadasa SD; Goodman CD; Lucke AJ; Skinner-Adams T; Sahama I; Haque A; Do TA; McFadden GI; Fairlie DP; Andrews KT
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3849-56. PubMed ID: 22508312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors.
    Hansen FK; Skinner-Adams TS; Duffy S; Marek L; Sumanadasa SD; Kuna K; Held J; Avery VM; Andrews KT; Kurz T
    ChemMedChem; 2014 Mar; 9(3):665-70. PubMed ID: 24497437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procainamide-SAHA Fused Inhibitors of hHDAC6 Tackle Multidrug-Resistant Malaria Parasites.
    Nardella F; Halby L; Dobrescu I; Viluma J; Bon C; Claes A; Cadet-Daniel V; Tafit A; Roesch C; Hammam E; Erdmann D; Mairet-Khedim M; Peronet R; Mecheri S; Witkowski B; Scherf A; Arimondo PB
    J Med Chem; 2021 Jul; 64(14):10403-10417. PubMed ID: 34185525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum.
    Ndong JM; Atteke C; Aubouy A; Bakary M; Lébibi J; Deloron P
    Trop Med Int Health; 2003 Jan; 8(1):25-9. PubMed ID: 12535246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of new artemisinin derivatives against Plasmodium falciparum clinical isolates from Gabon.
    Held J; Soomro SA; Kremsner PG; Jansen FH; Mordmüller B
    Int J Antimicrob Agents; 2011 May; 37(5):485-8. PubMed ID: 21392942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice.
    Agbor-Enoh S; Seudieu C; Davidson E; Dritschilo A; Jung M
    Antimicrob Agents Chemother; 2009 May; 53(5):1727-34. PubMed ID: 19223622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1).
    Kumar A; Dhar SK; Subbarao N
    J Mol Model; 2018 Aug; 24(9):232. PubMed ID: 30109440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Synthesis of Terephthalic Acid-Based Histone Deacetylase Inhibitors with Dual-Stage Anti-Plasmodium Activity.
    Stenzel K; Chua MJ; Duffy S; Antonova-Koch Y; Meister S; Hamacher A; Kassack MU; Winzeler E; Avery VM; Kurz T; Andrews KT; Hansen FK
    ChemMedChem; 2017 Oct; 12(19):1627-1636. PubMed ID: 28812327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial Activity.
    Mackwitz MKW; Hesping E; Antonova-Koch Y; Diedrich D; Woldearegai TG; Skinner-Adams T; Clarke M; Schöler A; Limbach L; Kurz T; Winzeler EA; Held J; Andrews KT; Hansen FK
    ChemMedChem; 2019 May; 14(9):912-926. PubMed ID: 30664827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil].
    Pradines B; Mabika Mamfoumbi M; Keundjian A; Lebeau C; Fusai T; Owono Medang M; Rogier C; Parzy D; Kombila M
    Bull Soc Pathol Exot; 1999 May; 92(2):91-4. PubMed ID: 10399596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of alkoxyamide-based histone deacetylase inhibitors against Plasmodium falciparum malaria parasites.
    Dawood WA; Fisher GM; Kinnen FJM; Anzenhofer C; Skinner-Adams T; Alves Avelar L; Asfaha Y; Kurz T; Andrews KT
    Exp Parasitol; 2024 Mar; 258():108716. PubMed ID: 38340779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.